Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01122186 · ClinicalTrials.gov registry record · NA
Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)
A NA study, sponsored by Hunter College of City University of New York.
- Completed
- Registry status
- NA
- Development phase
- 210
- Enrollment target
NCT01122186: Completed NA study, sponsored by Hunter College of City University of New York.
NCT01122186 is a NA study that has completed, run by Hunter College of City University of New York. The registered enrollment target is 210 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01122186, a NA study, has completed, sponsored by Hunter College of City University of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
Study Summary
The primary aim is to test an innovative 8-session intervention, based on Motivational Interviewing and Cognitive Behavioral Skills-Training for the co-occurrence of methamphetamine use and highly active antiretroviral therapy (HAART) non-adherence among methamphetamine using HIV+ MSM in NYC, compared to an 8-session educational (ED) condition. Participants in the intervention condition will report greater reductions in the number of days of methamphetamine use and viral load, and greater increases in CD4 counts and self-reported and objectively measured adherence than those in the education condition.
Primary Outcome
Participants in the intervention condition will report greater reductions in viral load, and greater increases in CD4 counts and self-reported adherence than those in the education comparison at at the end of the intervention period (3 months). Those in the intervention condition will also maintain greater reductions in viral load, and greater increases in CD4 counts and self-reported adherence than those in the education comparison condition at the three follow-up assessments (6, 9, and 12 mont
Interventions
- BEHAVIORAL Motivational Interviewing + Cognitive Behavioral Skills Training
- BEHAVIORAL Education Attention Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT01122186 record still lists
NCT01122186 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Motivational Interviewing + Cognitive Behavioral Skills Training is the first listed.
NCT01122186 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01122186 about?
NCT01122186 is a clinical study titled "Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)". The primary aim is to test an innovative 8-session intervention, based on Motivational Interviewing and Cognitive Behavioral Skills-Training for the co-occurrence of methamphetamine use and highly active antiretroviral therapy (HAART) non-adherence among methamphetamine using HIV+ MSM in NYC, compar...
What is the current status of trial NCT01122186?
This trial is currently completed. It is a NA study. The enrollment target is 210 participants. The study started on 2007-09. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01122186?
The interventions under investigation include: Motivational Interviewing + Cognitive Behavioral Skills Training (BEHAVIORAL), Education Attention Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT01122186?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01122186's enrollment target sits among peer trials
210 490th of 2000 higher than 1,505 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia